Accendra Health Reports Q1 2026 Earnings: Revenue Decline Amid Payor Exit
Accendra Health (ACH) reported a revenue decline of 6.8% in the first quarter of 2026, primarily due to exiting a large commercial payor relationship. However, excluding this impact, revenue would have increased by approximately 1%. The company's sleep therapy and home respiratory categories grew over 4%, while diabetes growth was partially offset by CGM declines.
Topics: adjusted_ebitda debt_and_liquidity payor_mix revenue sleep_therapy_growth